InvestorsHub Logo
Followers 125
Posts 5428
Boards Moderated 0
Alias Born 06/09/2020

Re: exwannabe post# 675725

Saturday, 03/02/2024 5:15:11 PM

Saturday, March 02, 2024 5:15:11 PM

Post# of 705611
There's nothing "have worked with in the past".

There's RIGHT NOW!

As I have now undisputably shown, the grant from NWBO, is directly traceble to the ATL-DC and poly-iclc trial and the upcoming Nature article.

The puzzle is carved out for you right here, but please do plead ignorance.



This is just ONE of a dozen of pieces of evidence corroborating that fact, but I keep adding to the pile, because paid shills like you DESPERATELY NEED to sow fud about these two combo trials and that DCVax-L is the CENTERPIECE of them.

Oh and by the way.

Robert Prins newest video regarding the SPORE 1 combo trial with DCVax-L and Keytruda.

Robert Prins





You are also gonna love the image of most of the team behind the DCVax-L and poly-iclc trial and coming Nature article.



And this image Robert Prins has reused ...



... from Linda Liaus presentations earlier on about the SPORE 1 project here

insert-text-here

Oh and btw.

JUST ONE piece of information. From UCLA Health. A fabulous article which you will hate.

Upper Left Corner: The SPORE 1 Project

The combo trial with DCVax-L + Keytruda (anti-PD-1) and CSF1R inhibition

DCVax-L .... BAAAAM


And zooming in .... for your viewing pleasure

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News